The AFR-PRELIEVE trial: a prospective, non-randomised, pilot study to assess the Atrial Flow Regulator (AFR) in heart failure patients with either preserved or reduced ejection fraction

Paitazoglou, Christina; ÖZDEMİR, Ramazan; Pfister, Roman; Bergmann, Martin; Bartunek, Jozef; KILIÇ, TEOMAN; Lauten, Alexander; Schmeisser, Alexander; ZOGHİ, MEHDİ; Anker, Stefan; Sievert, Horst; Mahfoud, Felix

doi:10.4244/eij-d-19-00342

The AFR-PRELIEVE trial: a prospective, non-randomised, pilot study to assess the Atrial Flow Regulator (AFR) in heart failure patients with either preserved or reduced ejection fraction

Copy For Citation

Paitazoglou C., ÖZDEMİR R., Pfister R., Bergmann M. W., Bartunek J., KILIÇ T., ...More

EUROINTERVENTION, vol.15, no.5, pp.403-410, 2019 (SCI-Expanded)

Publication Type: Article / Article
Volume: 15 Issue: 5
Publication Date: 2019
Doi Number: 10.4244/eij-d-19-00342
Journal Name: EUROINTERVENTION
Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
Page Numbers: pp.403-410
Keywords: atrial septal defect, chronic heart failure, clinical trials, innovation, DIASTOLIC FUNCTION, INTERATRIAL SHUNT, LAP-HF, DIAGNOSIS, PRESSURE, ECHOCARDIOGRAPHY, EXERCISE, SOCIETY, DEVICE, ADULT
Bezmialem Vakıf University Affiliated: Yes

Abstract

Aims: Reducing elevated left atrial pressure with an atrial septum shunt device is a possible treatment option in symptomatic heart failure patients. This study aimed to investigate the safety and feasibility of the Atrial Flow Regulator (AFR) in heart failure patients.